Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
(Q29620687)
scientific article (publication date: 4 January 2014)
scientific article (publication date: 4 January 2014)
Language: